drugset / Trial / NCT02171559
Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the relative bioavailability and the pharmacodynamics of dabigatran after switching from enoxaparin to dabigatran etexilate as compared to dabigatran etexilate alone
Timeline
- Start
- 2008-08
- Primary completion
- 2008-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 220 mg | Oral |
| Subject | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
Indications
No indication recorded.